NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 24 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $855,315 | -0.7% | 996,000 | -0.4% | 0.02% | +4.3% |
Q2 2023 | $861,250 | -1.2% | 1,000,000 | 0.0% | 0.02% | -4.2% |
Q1 2023 | $871,681 | -38.1% | 1,000,000 | -36.7% | 0.02% | -40.0% |
Q3 2022 | $1,408,000 | +2.8% | 1,580,000 | 0.0% | 0.04% | +8.1% |
Q2 2022 | $1,370,000 | -4.7% | 1,580,000 | 0.0% | 0.04% | +12.1% |
Q1 2022 | $1,438,000 | +1.8% | 1,580,000 | +2.7% | 0.03% | +13.8% |
Q4 2021 | $1,412,000 | – | 1,538,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 135,834,000 | $118,179,303 | 3.86% |
STEELHEAD PARTNERS LLC | 50,000,000 | $43,056,250 | 2.73% |
DeepCurrents Investment Group LLC | 45,000,000 | $38,654,893 | 1.53% |
Opti Capital Management, LP | 18,000,000 | $15,570,000 | 1.32% |
WOLVERINE ASSET MANAGEMENT LLC | 58,557,000 | $50,549,274 | 0.60% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 4,856,000 | $4,168,602 | 0.59% |
SHENKMAN CAPITAL MANAGEMENT INC | 7,180,000 | $6,246,794 | 0.49% |
Context Capital Management, LLC | 4,489 | $3,906 | 0.35% |
LINDEN ADVISORS LP | 37,025,000 | $31,949,534 | 0.34% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 14,000,000 | $12,091,110 | 0.25% |